40 CFR Ch. I (7–1–98 Edition) Pt. 414, App. A

Total Page:16

File Type:pdf, Size:1020Kb

40 CFR Ch. I (7–1–98 Edition) Pt. 414, App. A Pt. 414, App. A 40 CFR Ch. I (7±1±98 Edition) PSES and PSNS 1 n-Propyl alcohol/Hydrogenation of propionaldehyde, Oxo process Maximum SAN resin/Suspension polymerization Effluent characteristics Maximum for any for any Styrene/Dehydrogenation of ethylbenzene one day monthly average Styrene/Dehydration of methyl benzyl alco- hol (coproduct of propylene oxide) 1,3-Dichloropropylene ........................ 794 196 Diethyl phthalate ................................ 113 46 1-Tetralol, 1-Tetralone mix/Oxidation of Dimethyl phthalate ............................. 47 19 tetralin (1,2,3,4-Tetrahydronaphthalene) 4,6-Dinitro-o-cresol ............................. 277 78 3,3,3-Trifluoropropene/Catalyzed hydrogen Ethylbenzene ..................................... 380 142 fluoride exchange with chlorinated pro- Fluoranthene ...................................... 54 22 pane Fluorene ............................................. 47 19 Vinyl toluene/Dehydrogenation (thermal) of Hexachlorobenzene ........................... 794 196 Hexachlorobutadiene ......................... 380 142 ethyltoluene Hexachloroethane .............................. 794 196 Methyl Chloride .................................. 295 110 Copper Methylene Chloride ............................ 170 36 Methylhydroabietate/Esterification of Naphthalene ....................................... 47 19 Nitrobenzene ...................................... 6,402 2,237 hydroabietic acid (rosin) with methanol 2-Nitrophenol ...................................... 231 65 Acetaldehyde/Oxidation of ethylene with cu- 4-Nitrophenol ...................................... 576 162 pric chloride catalyst Phenanthrene ..................................... 47 19 Acetic acid/Catalytic oxidation of butane Pyrene ................................................ 48 20 Acetone/Dehydrogenation of isopropanol Tetrachloroethylene ........................... 164 52 Toluene .............................................. 74 28 Acrylamide/Catalytic hydration of acrylo- Total Cyanide ..................................... 1,200 420 nitrile Total Lead .......................................... 690 320 Acrylic acid/Oxidation of propylene via acro- Total Zinc 2 ......................................... 2,610 1,050 lein 1,2,4-Trichlorobenzene ...................... 794 196 Acrylonitrile/Propylene ammoxidation 1,1,1-Trichloroethane ......................... 59 22 Adipic acid/Oxidation of cyclohexanol- 1,1,2-Trichloroethane ......................... 127 32 Trichloroethylene ................................ 69 26 cyclohexanone mixture Vinyl Chloride ..................................... 172 97 Adipic acid/Oxidation of cyclohexane via cyclohexanol-cyclohexanone mixture 1 All units are micrograms per liter. 2 Total Zinc for Rayon Fiber Manufacture that uses the vis- Allynitrile/Allychloride + sodium cyanide cose process and Acrylic Fiber Manufacture that uses the zinc Aniline/Hydrogenation of nitrobenzene chloride/solvent process is 6,796 µg/l and 3,325 µg/l for maxi- Benzofurans, 2,3-Dihydro-2,2-dimethyl-7- mum for any one day and maximum for monthly average, respectively. benzofuranol/ from o-Nitrophenol + Meth- allyl chloride APPENDIX A TO PART 414ÐNON- n-Butyl alcohol/Hydrogenation of n- COMPLEXED METAL-BEARING WASTE Butyraldehyde, Oxo process 1,4-Butanediol/Hydrogenation of 1,4- STREAMS AND CYANIDE-BEARING butynediol WASTE STREAMS Butryolactone/Dehydrogenation of 1,4- Chromium butanediol Caprolactam/From cyclohexane via Methylhydroabietate/Esterification of cyclohexanone and its oxime hydroabietic acid (rosin) with methanol Lilian (hydroxydihydrocitronellal)/Hydra- Acrylic acid/Oxidation of propylene via acro- tion and oxidation of citronellol lein 1,2-Dichloroethane/Oxyhydrochlorination of N-butyl alcohol/Hydrogenation of n- ethylene Butyraldehyde, Oxo process Dialkyldithiocarbamates, metal salts/ Cyclohexanone/From phenol via Dialkylamines + carbon disulfide cyclohexanol by hydrogenation-dehydro- 2-Ethylhexanol/from n-Butyraldehyde by genation Aldo condensation and hydrogenation Fatty amines/Hydrogenation of fatty nitriles Fatty amines/Hydrogenation of fatty nitriles (batch) (batch) Helioptropin/Oxidation of isosafrole, chro- Geraniol/B-Myrcene + Hydrogen chloride, mium catalyst esterification of geranyl chloride, hydroly- Isobutanol/Hydrogenation of sis of geranyl acetate isobutyraldehyde, Oxo process Furfuryl alcohol/Hydrogenation of furfural Cyclohexyl Mercaptan/Cyclohexanol + Hy- Geranial (Citral)/Oxidation of geraniol (cop- drogen sulfide per catalyst) Ethyl Mercaptan/Ethanol + Hydrogen sulfide Glyoxal/Oxidation of ethylene glycol Methanol/H.P. Synthesis from natural gas Isobutanol/Hydrogenation of via synthetic gas isobutyraldehyde, Oxo process Oxo Alcohols, C7±C11/Carbonation & hydro- Isopropanol/Catalytic hydrogenation of ace- genation of C6±C10 Olefins tone Polyoxypropylene diamine/Polypropylene 2-Mercaptobenzothiazoles, copper salt/2- glycol + Ammonia Mercaptobenzothiazole + copper salt 232 VerDate 27<AUG>98 10:07 Aug 28, 1998 Jkt 179160 PO 00000 Frm 00228 Fmt 8010 Sfmt 8010 Y:\SGML\179160T.XXX pfrm01 PsN: 179160T Environmental Protection Agency Pt. 414, App. A Methanol/High pressure synthesis from natu- Nickel ral gas via synthetic gas Acetates, 7,11-Hexadecadien-1-ol Methanol/Low pressure synthesis from natu- (gossyplure)/Coupling reactions, low pres- ral gas via synthetic gas sure hydrogenation, esterification Methyl ethyl ketone/Dehydrogenation of sec- Acetates, 9-dodecen-1-ol (pheromone)/Cou- Butanol pling reactions, low pressure hydro- Oxo alcohols, C7±C11/Carbonation & hydro- genation, esterification genation of C6±C10 olefins Acrylic acid/oxidation of propylene via acro- Phenol/Liquid phase oxidation of benzoic lein acid Acrylonitrile/Propylene ammoxidation Polyoxyalkylene amines/Polyoxyalkylene n-Alkanes/Hydrogenation of C6-C22 alpha glycol + ammonia olefins (ethylene oligomers) Polyphenylene oxide/Solution polymeriza- Adiponitrile/Direct cyanation of butadiene tion of 2,6-xylenol by oxidative coupling Alkyl amines/Amination of alcohols (cuprous salt catalyst) 4-Aminoacetanilide/Hydrogenation of 4- Polyoxypropylene diamine/Polypropylene Nitroacetanilide glycol + Ammonia BTX/Hydrogenation of olefins (cyclohexenes) Quinaldine (dye intermediate)/Skraup reac- Terphenyls, hydrogenated/Nickel catalyst, tion of aniline + crotonaldehyde hydrogenation of terphenyl Silicones, silicone fluids/Hydrolysis and con- Bisphenol-A, hydrogenated densation of chlorosilanes (Biscyclohexanol-A)/Hydrogenation of Silicones, silicone rubbers/Hydrolysis and Bisphenol-A condensation of chlorosilanes Butadiene (1,3)/Extractive distillation of C±4 pyrolyzates Silicones, silicone specialties (grease, disper- n-Butanol/Hydrogenation of n- sion agents, defoamers & other products) Butyraldehyde, Oxo process Silicones: Silicone resins/Hydrolysis & con- 1,3-Butylene glycol/Hydrogenation of densation of methyl, phenyl & vinyl acetaldol chlorosilanes 1,4-Butanediol/Hydrogenation of 1,4- Silicones: Silicone fluids/Hydrolysis of butynediol chlorosilanes to acyclic & cyclic Butylenes (mixed)/Distillation pf C4 organosiloxanes pyrolyzates Styrene/Dehydration of a-Methylbenzyl alco- 4-Chloro-2-aminophenol/Hydrogenation of 4- hol (coproduct of propylene oxide) Chloro-2-nitrophenol Tetrachloroethylene (perchloroethylene)/ Lilial (hydroxydihydrocitronellal)/Hydration Oxyhydrochlorination of tetrachloroethane and oxidation of citronellol Tris(anilino)s-triazine/Cyanuric chloride + Cycloparaffins/Catalytic hydrogenation of aniline + cogeners aromatics in kerosene solvent Trichloroethylene/Oxyhydrochlorination of Cyclohexanol/Hydrogenation of phenol, dis- tetrachloroethane tillation Unsaturated polyester resin/Reaction of ma- Cyclohexanone/From phenol via leic anhydride + phthalic anhydride + pro- cyclohexanol by hydrogenation-dehydro- pylene glycol polyester with styrene or genation methyl methacrylate Dialkyldithiocarbamates, metal salts/ Dialkylamines + carbon disulfide Lead Ethylamine/Reductive amination of ethanol Ethylamines (mono, di, tri)/Reductive Alkyd resin/Condensation polymerization ammination (ammonia + hydrogen) of eth- Alkyd resins/Condensation polymerization of anol phthalic anhydride + glycerin + vegetable Isoeugenol, high % trans/Separation of oil esters mixed cis & trans isoeugenols Dialkydithiocarbamates, metal salts/ 2-Ethylhexanol/from n-Butyraldehyde by Dialkylamines + carbon disulfide Aldol condensation and hydrogenation Thiuram (dimethyldithiocarbamate) Fatty acids, hydrogenated/tallow & coco hexasulfide/Dimethyldithiocarbamate + acids + Hydrogen sulfur Fatty amines/Hydrogenation of fatty nitriles Triphenylmethane dyes (methyl violet)/Con- (batch) densation of Formaldehyde + N- Fatty amines/Hydrogenation of tallow & Methylaniline + N,N-dimethylaniline, oxi- coco nitriles dation of reaction product Glyoxal-urea formaldehyde textile resin/con- 4,4′-Bis-(N,N-dimethylaniline) carbinol, densation to N-bis(hydroxymethyl) ureas & Michler's hydrol/Oxidation of 4,4′-Methyl- N,N′-(dihydroxyethyl) ureas ene-bis(N,N-dimethylaniline) with lead 11-hexadecenal/Coupling rxns, low pressure oxide hydrogenation Naphthenic acid salts Hexahydrophthalic anhydride/Condensation Stearic acid, metal salts/Neutralization with of butadiene & maleic anhydride (Diels- a metallic base Alder reaction) + hydrogenation 233 VerDate 27<AUG>98 10:07 Aug 28, 1998 Jkt 179160 PO 00000 Frm 00229 Fmt 8010 Sfmt 8010 Y:\SGML\179160T.XXX pfrm01 PsN: 179160T Pt. 414, App. A 40 CFR Ch. I (7±1±98 Edition) Isobutanol/Hydrogenation of Acrylic fibers (85% polyacrylonitrile)
Recommended publications
  • An Aged Reaction Revisited
    TETRAHEDRON Pergamon Tetrahedron 56 (2000) 9705±9711 2-Alkyl-4,6-dialkylamino-1,3,5-triazines via Grignard Alkylation of Cyanuric Chloride: An Aged Reaction Revisited Rita Menicagli,* Simona Samaritani and Valeria Zucchelli Dipartimento di Chimica e Chimica Industriale and Centro di Studi del CNR per le Macromolecole Stereordinate ed Otticamente Attive, Via Risorgimento 35, 56126 Pisa, Italy Received 24 July 2000; revised 8 September 2000; accepted 28 September 2000 AbstractÐSuitable one-pot reaction conditions are suggested to prepare, in good overall yields, some 2-(alk-1 0-ynyl)- and 2-alkyl-4,6- dialkylamino-1,3,5-triazines via reaction of cyanuric chloride with Grignard reagents followed by amination. q 2000 Elsevier Science Ltd. All rights reserved. In our studies1 concerning the protection of paper against The reaction between a benzene (CAUTION) solution of 1 pathogenic fungi, we found that 2-(alk-1 0-ynyl)-4,6- and a THF solution of alk-1 0-ynylmagnesium halides has dimethoxy-1,3,5-triazines showed an appreciable biostatic been reported to afford 2-(alk-1 0-ynyl)-4,6-dichloro-1,3,5- activity.2 Taking into account that alkylamino derivatives of triazines in 50±60% yield.6a Since the puri®cation of these 1,3,5-triazine are generally better biostatic agents than intermediates might have caused an appreciable loss of the alkoxy derivatives,1 preparation of 2-(alk-1 0-ynyl)-4,6- product owing to the well known8 reactivity of the C±Cl dialkylamino-1,3,5-triazines was necessary in order to bonds and the treatment of the crude products with nucleo- compare their antifungal activities with those of 2-(alk-1 0- philes would have lead to complex mixtures of compounds, ynyl)-4,6-dimethoxy-1,3,5-triazines.
    [Show full text]
  • United States Patent Office Patented Apr
    2,881,193 United States Patent Office Patented Apr. 7, 1959 2 propionic acid, glutamic acid, aspartic acid and the like. 2,881,193 Particularly satisfactory results are obtained in the PURIFICATION OF N-HIGHER FATTY ACED purification of N-higher fatty acyl sarcosine compounds AMDES OF LOWER MONOAMINOCAR such as salts of N-lauroyl sarcosine, N-myristoyl sarcosine BOXYFLIC ACDS and N-palmitoyl sarcosine, e.g., sodium, potassium salts thereof. Morton Batlan Epstein, Linden, N.J., assignor to Colgate While the present invention is broadly applicable to Palmolive Company, Jersey City, N.J., a corporation mixtures of the amide and higher fatty acid material of Delaware as indicated, it is effective particularly with the reaction No Drawing. Application May 9, 1955 product produced in the following manner and results Serial No. 507,177 in an amide material substantially free from soap and the like. Thus, the amide may be formed by condensing 6 Claims. (C. 260-404) a higher fatty acyl halide with a salt of said amino car boxylic acid, which has a primary or secondary amino The present invention relates to a novel process for 5 group, in an aqueous alkaline medium. purifying N-higher. acyl amide compounds. More This condensation reaction may be performed under specifically the invention is of a method for removing various suitable conditions. The reaction may be con impurities of the fatty acid or soap type from compounds ducted by mixing suitable proportions of the reactants which are N-higher fatty amides of lower monoamino in an aqueous medium. In general, the reaction is effected carboxylic acids or salts thereof.
    [Show full text]
  • The Impact of D-Cycloserine and Sarcosine on in Vivo Frontal Neural
    Yao et al. BMC Psychiatry (2019) 19:314 https://doi.org/10.1186/s12888-019-2306-1 RESEARCH ARTICLE Open Access The impact of D-cycloserine and sarcosine on in vivo frontal neural activity in a schizophrenia-like model Lulu Yao1, Zongliang Wang1, Di Deng1, Rongzhen Yan1, Jun Ju1 and Qiang Zhou1,2* Abstract Background: N-methyl-D-aspartate receptor (NMDAR) hypofunction has been proposed to underlie the pathogenesis of schizophrenia. Specifically, reduced function of NMDARs leads to altered balance between excitation and inhibition which further drives neural network malfunctions. Clinical studies suggested that NMDAR modulators (glycine, D-serine, D-cycloserine and glycine transporter inhibitors) may be beneficial in treating schizophrenia patients. Preclinical evidence also suggested that these NMDAR modulators may enhance synaptic NMDAR function and synaptic plasticity in brain slices. However, an important issue that has not been addressed is whether these NMDAR modulators modulate neural activity/spiking in vivo. Methods: By using in vivo calcium imaging and single unit recording, we tested the effect of D-cycloserine, sarcosine (glycine transporter 1 inhibitor) and glycine, on schizophrenia-like model mice. Results: In vivo neural activity is significantly higher in the schizophrenia-like model mice, compared to control mice. D-cycloserine and sarcosine showed no significant effect on neural activity in the schizophrenia-like model mice. Glycine induced a large reduction in movement in home cage and reduced in vivo brain activity in control mice which prevented further analysis of its effect in schizophrenia-like model mice. Conclusions: We conclude that there is no significant impact of the tested NMDAR modulators on neural spiking in the schizophrenia-like model mice.
    [Show full text]
  • SAFETY DATA SHEET Nonflammable Gas Mixture: Cyanogen Chloride 1-999Ppm / Nitrogen 99%
    SAFETY DATA SHEET Nonflammable Gas Mixture: Cyanogen Chloride 1-999ppm / Nitrogen 99% Section 1. Identification GHS product identifier : Nonflammable Gas Mixture: Cyanogen Chloride 1-999ppm / Nitrogen 99% Other means of : Not available. identification Product use : Synthetic/Analytical chemistry. SDS # : 012226 Supplier's details : Airgas USA, LLC and its affiliates 259 North Radnor-Chester Road Suite 100 Radnor, PA 19087-5283 1-610-687-5253 24-hour telephone : 1-866-734-3438 Section 2. Hazards identification OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Classification of the : GASES UNDER PRESSURE - Compressed gas substance or mixture GHS label elements Hazard pictograms : Signal word : Warning Hazard statements : Contains gas under pressure; may explode if heated. May displace oxygen and cause rapid suffocation. Precautionary statements General : Read and follow all Safety Data Sheets (SDS’S) before use. Read label before use. Keep out of reach of children. If medical advice is needed, have product container or label at hand. Close valve after each use and when empty. Use equipment rated for cylinder pressure. Do not open valve until connected to equipment prepared for use. Use a back flow preventative device in the piping. Use only equipment of compatible materials of construction. Prevention : Not applicable. Response : Not applicable. Storage : Protect from sunlight when ambient temperature exceeds 52°C/125°F. Store in a well- ventilated place. Disposal : Not applicable. Hazards not otherwise : In addition to any other important health or physical hazards, this product may displace classified oxygen and cause rapid suffocation. Section 3. Composition/information on ingredients Substance/mixture : Mixture Other means of : Not available.
    [Show full text]
  • Methods for the Determination of Chlorine, Hydrogen-Sulfide, and Hydrogen-Cyanide Utilizing Permeation Sampling
    Louisiana State University LSU Digital Commons LSU Historical Dissertations and Theses Graduate School 1981 Methods for the Determination of Chlorine, Hydrogen-Sulfide, and Hydrogen-Cyanide Utilizing Permeation Sampling. James Keith Hardy Louisiana State University and Agricultural & Mechanical College Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses Recommended Citation Hardy, James Keith, "Methods for the Determination of Chlorine, Hydrogen-Sulfide, and Hydrogen-Cyanide Utilizing Permeation Sampling." (1981). LSU Historical Dissertations and Theses. 3599. https://digitalcommons.lsu.edu/gradschool_disstheses/3599 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact [email protected]. INFORMATION TO USERS This was produced from a copy of a document sent to us for microfilming. While the most advanced technological means to photograph and reproduce this document have been used, the quality is heavily dependent upon the quality of the material submitted. The following explanation of techniques is provided to help you understand markings or notations which may appear on this reproduction. 1.The sign or “target” for pages apparently lacking from the document photographed is “Missing Page(s)”. If it was possible to obtain the missing page(s) or section, they are spliced into the Him along with adjacent pages. This may have necessitated cutting through an image and. duplicating adjacent pages to assure you of complete continuity. 2. When an image on the Him is obliterated with a round black mark it is an indication that the film inspector noticed either blurred copy because of movement during exposure, or duplicate copy.
    [Show full text]
  • Toxicological Profile for Cyanide
    CYANIDE 141 5. PRODUCTION, IMPORT/EXPORT, USE, AND DISPOSAL 5.1 PRODUCTION The demand for hydrogen cyanide in the United States during 2000 was 1.615 billion pounds, up slightly from 1.605 billion pounds in 1999 (CMR 2001). Production of hydrogen cyanide in 2003 was 2.019 billion pounds in the United States (FAS 2005). The demand for hydrogen cyanide was projected to be 1.838 billion pounds in 2004 (CMR 2001; NYSDOH 2005). Major producers of hydrogen cyanide are Adisseo USA, Inc. (Institute, West Virginia); Cyanco Co. (Winnemucca, Nevada); Cytec Industries (Waggoman, Louisiana); Degussa Corp. (Theodora, Alabama); The Dow Chemical Company (Freeport, Texas); E.I. du Pont de Neumours and Company (Memphis, Tennessee; Beaumont, Texas); Innovene (Green Lake, Texas and Lima, Ohio); Invista, Inc. (Orange, Texas and Victoria, Texas); Rhom and Haas Texas Inc. (Deer Park, Texas); Solutia, Inc. (Alvin, Texas); Sterling Chemicals, Inc. (Texas City, Texas); and Syngenta Crop Protection (St. Garbiel, Louisiana) (SRI 2005). The combined annual production capacity of these plants is approximately 2.036 billion pounds (SRI 2005). As of February 2005, the following companies produced other cyanide compounds in the United States (SRI 2005): ammonium Crompton, Taft, Louisiana; and Mallinckrodt, Inc., St. Louis, Missouri thiocyanate: cyanogen: Matheson Gas Products, Inc., Gloucester, Massachusetts potassium cyanide: DuPont Chemical Company, Memphis, Tennessee; and The Dow Chemical Company, Nashua, New Hampshire potassium silver Engelhard Corporation, Union, New Jersey; and Metalor Technologies USA, North cyanide: Attleboro, Massachusetts Facilities in the United States producing sodium cyanide and their annual capacity (in millions of pounds) in 2005 include: Cyanco Co., Winnemucca, Nevada (86); and E.I.
    [Show full text]
  • Abbreviations of Chemical Warfare Agents, 152 Acetylcholinesterase
    Index Abbreviations of chemical warfare agents, Blood ChE inhibition, nerve agent critical 152 toxic effect on, 23 Acetylcholinesterase (AChE) inhibition, Blood ChE inhibition, nerve agent species nerve agents and, 18 variation of, 21 Acetylthiocholine iodide, RBC-ChE activ­ Blood cholinesterases, nerve agent effects ity and, 22 on, 20 AChE (acetylcholinesterase) inhibition, Butyrylcholinesterase (plasma-ChE), nerve agents and, 18 nerve agent effects on, 20 Acronyms for chemical warfare agents, 152 Acute inhalation toxicity, CK and, 114 Carboxylesterases (aliesterases), nerve Acute toxicity, CK (cyanogen chloride) agent effects on, 21 and, 113 Carcinogenicity, CK and, 122 Acute toxicity, GA and, 68 Carcinogenicity, GA and, 73 Acute toxicity, GB and, 78 Carcinogenicity, GB and, 90 Acute toxicity, GD and, 94 Carcinogenicity, HD and, 38 Acute toxicity, HD and, 30 Carcinogenicity, HN2 and, 53 Acute toxicity, HN2 and, 51 Carcinogenicity, HT and, 49 Acute toxicity, HT and, 49 Carcinogenicity, lewisite and, 107 Acute toxicity, lewisite and, 103 Carcinogenicity, VX and, 61 Acute toxicity, T sulfur mustard and, 50 ChE (cholinesterase), nerve agent effects Acute toxicity, VX and, 54 on, 20 Agent CK, see CK or cyanogen chloride ChE inhibition, nerve agent potency on, Agent GA, see GA or Tabun 23 Agent GB, see GB or Sarin Chemical warfare agent disposal tech­ Agent GD, see GD or Soman niques,3 Agent HD, see HD or Sulfur mustard HD Chemical warfare agent non-stockpile Agent HN2, see HN2 or Nitrogen mus- sites U.S., 4 tard Chemical warfare agents, 1 ff. Agent HT, see HT or Sulfur mustard HT Chemical warfare agents, acronyms/abbre­ Agent L, see L or Lewsite viations of, 152 Agent T, see T Sulfur mustard Chemical warfare agents, air exposure lim­ Agent VX, see VX its of, 7 Aliesterases (carboxylesterases), nerve Chemical warfare agents, environmental agent effects on, 21 cleanup of, 3 Anticholinesterase agents, 18 Chemical warfare agents, environmental Army chemical destruction, 3 ff.
    [Show full text]
  • Threshold Limit Values (TLV) and Immediately Dangerous to Life and Health (IDLH) Values
    Reference Information 442 Threshold Limit Values (TLV) and Immediately Dangerous to Life and Health (IDLH) values Matheson Tri-Gas assumes no responsibility for the accuracy of the TLV TLV information listed. As TLV and IDLH values may change, the current Substance TWA STEL IDLH guidelines from the following sources should be consulted for up-to-date accuracy. Fluorine 1 2 25 Formaldehyde - 0.3C 20 Sources: TLV-TWA and TLV-STEL data extracted from the 2005 Threshold Limit Values & Biological Exposure Indices, copyright 2005 by the American Conference of Formic Acid 5 10 30 Governmental Industrial Hygienists (ACGIH). IDLH values extracted from the Furfural 2 - 100 NIOSH Pocket Guide to Chemical Hazards, 2004 published by the National Institute Gasoline 300 500 - for Occupational Safety and Health (NIOSH). Germanium tetrahydride 0.2 - - Note: All concentrations in parts per million (ppm) unless otherwise noted. Glutaraldehyde - 0.05C - “C” indicates Ceiling Limit. Heptane 400 500 750 TLV TLV n-Hexane 50 - 1,100 Substance TWA STEL IDLH Hydrazine 0.01 - 50 Acetaldehyde - 25C 2,000 Hydrogen Bromide - 2C 30 Acetic Acid 10 15 50 Hydrogen Chloride - 2C 50 Acetone 500 750 2,500 Hydrogen Cyanide - 4.7C 50 Acetonitirle 20 - 500 Hydrogen Fluoride 0.5 2C 30 Acrolein - 0.1C 2 Hydrogen Peroxide 1 - 75 Acrylonitrile 2 - 85 Hydrogen Selenide 0.05 - 1 Ammonia 25 35 300 Hydrogen Sulfide 10 15 100 Arsine 0.05 - 3 Iodine - 0.1C 2 Benzene 0.5 2.5 500 Isopropyl Alcohol 200 400 2,000 Boron Trifluoride - 1C 25 Methyl Alcohol 200 250 6,000 Bromine 0.1 0.2 3 Methylamine
    [Show full text]
  • NIOSH Guidance -Filtration and Air Cleaning Systems to Protect Building
    Guidance for Filtration and Air-Cleaning Systems to Protect Building Environments from Airborne Chemical, Biological, or Radiological Attacks Department of Health and Human Services Centers for Disease Control and Prevention National Institute for Occupational Safety and Health April 2003 ii Ordering Information To receive documents or other information about occupational safety and health topics, contact the National Institute for Occupational Safety and Health (NIOSH) at NIOSH Publications Dissemination 4676 Columbia Parkway Cincinnati, OH 45226-1998 Telephone: 1-800-35-NIOSH (1-800-356-4674) Fax: 1-513-533-8573 E-mail: [email protected] or visit the NIOSH Web site at www.cdc.gov/niosh This document is in the public domain and may be freely copied or reprinted. Disclaimer: Mention of any company, product, policy, or the inclusion of any reference does not constitute endorse- ment by NIOSH. DHHS (NIOSH) Publication No. 2003-136 iii Foreword The Occupational Safety and Health Act of 1970 [Public Law 91-596] assures so far as possible every working man and woman in the Nation safe and healthful working conditions. The Act charges the National Institute for Occupational Safety and Health (NIOSH) with conducting research and making science-based recommenda- tions to prevent work-related illness, injury, disability, and death. On October 8, 2001, the President of the United States established by executive order the Office of Homeland Security (OHS), which is mandated “to develop and coordinate the implementation of a com- prehensive national strategy to secure the United States from ter- rorist threats or attacks.” In January 2002, the OHS formed the Interagency Workgroup on Building Air Protection under the Medical and Public Health Preparedness Policy Coordinating Committee of the OHS.
    [Show full text]
  • Incorporation of Sarcosine Into the Actinomycins Synthesized by Streptomyces Antibioticus
    82 Biochem. J. (1964) 90, 82 Incorporation of Sarcosine into the Actinomycins Synthesized by Streptomyces antibioticus By 0. CIFERRI, A. ALBERTINI AND G. CASSANI Department of Genetics, University of Pavia, Italy (Received 3 April 1963) Sarcosine is an amino acid apparently not Micro-organism. Streptomyces antibioticus (no. 1692 of widely distributed in Nature. As a free amino acid, the Culture Collection of the Botanical Institute of this sarcosine has been demonstrated in the radial University) was maintained on slants ofEmerson's medium caeca of the starfish Astropecten aurantiacus (Emerson, Whiffen, Bohonas & DeBoer, 1946). A suspen- sion of spores from such slants was used to inoculate the (Kossel & Edlbacher, 1915), in the muscles of vegetative medium: soya-bean flour 20 g., glucose 10 g., Elasmobranchii (Tarr, 1958) and in the reindeer tap water 1000 ml. (adjusted to pH 7-4 with N-NaOH). The moss, Cladonia itlvatica (Linko, Alfthan, Miettinen culture was incubated at 280 for 48 hr. on an alternating & Virtanen, 1953). Sarcosine has been found shaker. The cells were recovered by centrifuging in the bound in peptides in the antibiotics of the actino- cold, washed twice with the fermentation medium (see mycin (Dalgliesh, Johnson, Todd & Vining, 1950) below) and suspended in the same solution to give a cell and etamycin (Sheehan, Zachau & Lawson, 1957) concentration twice that of the vegetative-medium suspen- groups. The reported presence of sarcosine in the sion. A portion (5 ml.) of this suspension was used to hydrolysate of groundnut protein (Haworth, inoculate 100 ml. of the synthetic galactose-glutamic acid ('fermentation') medium (Katz & Goss, 1960).
    [Show full text]
  • 230 Subpart K—Indirect Discharge Point Sources
    § 414.110 40 CFR Ch. I (7±1±00 Edition) [52 FR 42568, Nov. 5, 1987, as amended at 58 PSES and PSNS 1 FR 36893, July 9, 1993] Maximum Effluent characteristics Maximum for any for any monthly Subpart KÐIndirect Discharge one day average Point Sources Acenaphthene ................................... 47 19 Anthracene ........................................ 47 19 SOURCE: 58 FR 36893, July 9, 1993, unless Benzene ............................................ 134 57 otherwise noted. Bis(2-ethylhexyl) phthalate ................ 258 95 Carbon Tetrachloride ......................... 380 142 § 414.110 Applicability; description of Chlorobenzene .................................. 380 142 Chloroethane ..................................... 295 110 the subcategory of indirect dis- Chloroform ......................................... 325 111 charge point sources. Di-n-butyl phthalate ........................... 43 20 1,2-Dichlorobenzene .......................... 794 196 The provisions of this subpart are ap- 1,3-Dichlorobenzene .......................... 380 142 plicable to the process wastewater dis- 1,4-Dichlorobenzene .......................... 380 142 charges resulting from the manufac- 1,1-Dichloroethane ............................ 59 22 ture of the OCPSF products and prod- 1,2-Dichloroethane ............................ 574 180 1,1-Dichloroethylene .......................... 60 22 uct groups defined by § 414.11 from any 1,2-trans-Dichloroethylene ................. 66 25 indirect discharge point source. 1,2-Dichloropropane .........................
    [Show full text]
  • A Pilot Open-Label Trial of Use of the Glycine Transporter I Inhibitor
    nal atio Me sl d n ic a in r e T Yang, et al., Transl Med (Sunnyvale) 2014, 4:2 Translational Medicine DOI: 10.4172/2161-1025.1000127 ISSN: 2161-1025 Research Article Open Access A Pilot Open-Label Trial of Use of the Glycine Transporter I Inhibitor, Sarcosine, in High-Functioning Children with Autistic Disorder Pinchen Yang1, Hsien-Yuan Lane2, Cheng-Fang Yen1, Chen-Lin Chang 3,4* 1Department of Psychiatry, College of Medicine, Kaohsiung Medical University and Kaohsiung Medical University Hospital, Kaohsiung, Taiwan 2Institute of Clinical Medical Science & Departments of Psychiatry, China Medical University and Hospital, Taichung, Taiwan 3Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University and Kaohsiung Medical University Hospital, Kaohsiung, Taiwan 4Department of Psychiatry, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan *Corresponding author: Chen-Lin Chang, 100, Shin Chuan 1 st Rd, Kaohsiung 807, Taiwan, Graduate Institute of Medicine, Kaohsiung Medical University and Kaohsiung Medical University Hospital & Department of Psychiatry, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan, Tel:+886-9-36360220; Fax: +886-7-3134761; E-mail: [email protected] Rec date: Apr 01, 2014; Acc date: Apr 17, 2014; Pub date: Apr 22, 2014 Copyright: © 2014 Yang P et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract This open-label trial examined the efficacy and safety of a glycine transporter I inhibitor, sarcosine, in the 24-week treatment of high-functioning children with autistic disorder.
    [Show full text]